{
  "text": "Figure 1. Study Design\n7\" METHODS gure 1. Study Desig\nJ \u2122\n@) | NTRO D UCTI O N + This multicohort phase I/II trial, evaluated the safety and efficacy of Diseaserepeciiciechortst 2-stage expansion Dose optimization\nPe oie een  vaneonn od + Dysregulation of Enhancer of Zeste Homolog 2 (EZH2) activity cially affects cancer progression and drug resistance, especialy monotherapy in patients with ARID TAmut OCC (Cohort M2) of EC (Cohort M3)\nin tumors with AT-Rich Interaction Domain 1(ARID1A) mutations...",
  "full_text_length": 17236,
  "processing_time": 26.219642999989446,
  "word_count": 3162,
  "char_count": 17236,
  "confidence": 0.7967901650387336,
  "metadata": {
    "engine": "Tesseract",
    "lang": "eng",
    "config": "--psm 6",
    "total_words": 3162,
    "avg_confidence": 79.67901650387336,
    "min_confidence": 1,
    "max_confidence": 97,
    "image_shape": [
      3500,
      6000,
      3
    ],
    "preprocessing_applied": false
  },
  "errors": [],
  "model_name": "Tesseract",
  "timestamp": "2025-10-29T14:52:57.420412",
  "memory_usage_mb": 63.27271270751953,
  "file_hash": "54b0e14f397636c75471bcfae8055a5f",
  "chars_per_second": 657.3697437454407
}